Skip to product information
1 of 1

Marco Viti

Iodine Marco Viti 7 %/5 % 50 ml alcoholic skin solution

Iodine Marco Viti 7 %/5 % 50 ml alcoholic skin solution

Regular price €5,95
Regular price €6,40 Sale price €5,95
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

50ml

EAN

030336034

MINSAN

030336034

View full details

In compliance with article 118 "authorization of advertising to the public" of the legislative decree of 24 April 2006, number 219

INDICATIONS

Disinfection of intact skin for occasional treatments.

CONTRAINDICATIONS

Hypersensitivity to the active substances or to any of the excipients. Generally contraindicated during pregnancy (see par. 4.6). Do not use in children under 6 months of age.

WARNINGS AND PRECAUTIONS FOR USE

For external use only. Do not ingest. Avoid contact with eyes. Prolonged application can cause irritation and caustification of the treated surface, therefore the medicine must not be used for prolonged treatments. The medicine must only be applied to intact and undamaged skin, as in addition to causing irritation, it delays the healing of wounds and abrasions. Use, especially if prolonged, can give rise to sensitization phenomena. In this case, stop treatment and adopt suitable therapeutic measures. To avoid excessive absorption of iodine, do not cover the treated skin area with occlusive bandages. In case of use for prolonged periods on large body surfaces, on mucous membranes or under occlusive dressings, particularly in children and patients with thyroid disorders, it is necessary to carry out thyroid function tests. Since iodine can alter the function of the thyroid, it is recommended to be used with caution in subjects with thyroid disease, in patients over 45 years of age or with goiter. In pediatric age use only in case of real need and under medical supervision. Stop treatment at least 10 days before carrying out a scan with labeled iodine. Following treatment, the results of thyroid function tests may be altered, especially in premature newborns.

INTERACTIONS

If it comes into contact with acetone, elemental iodine forms a pungent irritant compound. When evaluating interactions with other drugs, the possible systemic effects of iodine must be taken into consideration, although when administered locally in the recommended manner it is absorbed only in small quantities. The effects of iodine and iodide on the thyroid can be altered by other compounds including amiodarone and lithium.

SIDE EFFECTS

Below are the side effects of iodine, organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. Pathologies of the skin and subcutaneous tissue Burning or irritation, acneiform eruptions, iododerma, delayed healing of damaged tissues. Inhalation of iodine vapors is very irritating to the mucous membranes. Immune system disorders Hypersensitivity reactions including urticaria, angioedema, skin haemorrhages or purpura, fever, arthralgia, lymphadenopathy and eosinophilia. Iodine, when administered topically as recommended, is absorbed only in small quantities with minimal systemic effects. However, the adverse reactions due to systemic effects of the drug are listed below, which could occur in cases of anomalous absorption (abundant, prolonged use or with occlusion of the treated skin area). Endocrine disorders Effects on the thyroid can cause goiter and hypothyroidism, as well as hyperthyroidism (Basedow's disease). Goiter and hypothyroidism can also occur in newborns exposed to iodide during pregnancy. Iodine can interfere with thyroid function tests. Psychiatric disorders Depression, insomnia. Nervous system disorders Headache. Gastrointestinal disorders Nausea, vomiting, diarrhea. Reproductive system and breast disorders Impotence. Injury, poisoning and procedural complications Prolonged use can cause a series of adverse effects collectively called "iodism", some of which may be due to hypersensitivity. These adverse effects include metallic taste, increased salivation, burning, and sore mouth; acute rhinitis, coryza-like syndrome, swelling and inflammation of the throat, irritation and swelling of the eyes and increased tearing may also occur. Pulmonary edema, dyspnea, and bronchitis may develop.

1 of 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.